TY  - GEN
AU  - Hansen,N
AU  - Ågerstam,H
AU  - Wahlestedt,M
AU  - Landberg,N
AU  - Askmyr,M
AU  - Ehinger,M
AU  - Rissler,M
AU  - Lilljebjörn,H
AU  - Johnels,P
AU  - Ishiko,J
AU  - Melo,J V
AU  - Alexander,W S
AU  - Bryder,D
AU  - Järås,M
AU  - Fioretos,T
TI  - SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function
SN  - 1476-5551
PY  - 2013///0228
KW  - Animals
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Blotting, Western
KW  - Bone Marrow Cells
KW  - metabolism
KW  - Disease Models, Animal
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Flow Cytometry
KW  - Fusion Proteins, bcr-abl
KW  - pharmacology
KW  - Gene Expression Profiling
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hematopoietic Stem Cells
KW  - Immunoenzyme Techniques
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - etiology
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Mice, Knockout
KW  - Oligonucleotide Array Sequence Analysis
KW  - Phosphorylation
KW  - RNA, Messenger
KW  - Real-Time Polymerase Chain Reaction
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - STAT5 Transcription Factor
KW  - Suppressor of Cytokine Signaling Proteins
KW  - physiology
KW  - Survival Rate
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2012.169
ER  -